1. |
Zuberi SM, Wirrell E, Yozawitz E, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 2022, 63(6): 1349-1397.
|
2. |
Symonds JD, Elliot KS, Shetty J, et al. Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants. Brain, 2021, 144: 2879-2891.
|
3. |
Symonds JD, Zuberi SM, Stewart K, et al. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain, 2019, 142: 2303-2318.
|
4. |
Rech ME, McCarthy JM, Chen CA, et al. Phenotypic expansion of Bosch-Boonstra-Schaaf optic atrophy syndrome and further evidence for genotype-phenotype correlations. Am J Med Genet A, 2020, 182(6): 1426-1437.
|
5. |
Bosch DG, Boonstra FN, Gonzaga-Jauregui C, et al. NR2F1 mutations cause optic atrophy with intellectual disability. Am J Hum Genet, 2014, 94(2): 303-309.
|
6. |
Hino-Fukuyo N, Kikuchi A, Arai-Ichinoi N, et al. Genomic analysis identifies candidate pathogenic variants in 9 of 18 patients with unexplained West syndrome. Hum Genet, 2015, 134(6): 649-658.
|
7. |
Chen CA, Bosch DG, Cho MT, et al. The expanding clinical phenotype of Bosch-Boonstra-Schaaf optic atrophy syndrome: 20 new cases and possible genotype-phenotype correlations. Genet Med, 2016, 18(11): 1143-1150.
|
8. |
Dimassi S, Labalme A, Ville D, et al. Whole-exome sequencing improves the diagnosis yield in sporadic infantile spasm syndrome. Clin Genet, 2016, 89(2): 198-204.
|
9. |
Kaiwar C, Zimmermann MT, Ferber MJ, et al. Novel NR2F1 variants likely disrupt DNA binding: molecular modeling in two cases, review of published cases, genotype-phenotype correlation, and phenotypic expansion of the Bosch-Boonstra-Schaaf optic atrophy syndrome. Cold Spring Harb Mol Case Stud, 2017, 3(6): a002162.
|
10. |
Martín-Hernández E, Rodríguez-García ME, Chen CA, et al. Mitochondrial involvement in a Bosch-Boonstra-Schaaf optic atrophy syndrome patient with a novel de novo NR2F1 gene mutation. J Hum Genet, 2018, 63(4): 525-528.
|
11. |
Park SE, Lee JS, Lee ST, et al. Targeted panel sequencing identifies a novel NR2F1 mutations in a patient with Bosch-Boonstra-Schaaf optic atrophy syndrome. Ophthalmic Genet, 2019, 40(4): 359-361.
|
12. |
Bojanek EK, Mosconi MW, Guter S, et al. Clinical and neurocognitive issues associated with Bosch-Boonstra-Schaaf optic atrophy syndrome: a case study. Am J Med Genet A, 2020, 182(1): 213-218.
|
13. |
Bertacchi M, Romano AL, Loubat A, et al. NR2F1 regulates regional progenitor dynamics in the mouse neocortex and cortical gyrification in BBSOAS patients. EMBO J, 2020, 39(13): e104163.
|
14. |
Mio C, Fogolari F, Pezzoli L, et al. Missense NR2F1 variant in monozygotic twins affected with the Bosch-Boonstra-Schaaf optic atrophy syndrome. Mol Genet Genomic Med, 2020, 8(7): e1278.
|
15. |
Jezela-Stanek A, Ciara E, Jurkiewicz D, et al. The phenotype-driven computational analysis yields clinical diagnosis for patients with atypical manifestations of known intellectual disability syndromes. Mol Genet Genomic Med, 2020, 8(9): e1263.
|
16. |
Hino-Fukuyo N, Kikuchi A, Yokoyama H, et al. Long-term outcome of a 26-year-old woman with West syndrome and an nuclear receptor subfamily 2 group F member 1 gene (NR2F1) mutation. Seizure, 2017, 50: 144-146.
|
17. |
Walsh S, Gösswein SS, Rump A, et al. Novel dominant-negative NR2F1 frameshift mutation and a phenotypic expansion of the Bosch-Boonstra-Schaaf optic atrophy syndrome. Eur J Med Genet, 2020, 63(10): 104019.
|
18. |
Zou W, Cheng L, Lu S, et al. A de novo nonsense mutation in the N-terminal of ligand-binding domain of NR2F1 gene provoked a milder phenotype of BBSOAS. Ophthalmic Genet, 2020, 41(1): 88-89.
|
19. |
Hobbs MM, Wolters WC, Rayapati AO. Bosch-boonstra-schaaf optic atrophy syndrome presenting as new-onset psychosis in a 32-year-old man: a case report and literature review. J Psychiatr Pract, 2020, 26(1): 58-62.
|
20. |
Kocaaga A, Yimenicioglu S, Gürsoy HH. Novel NR2F1 variant identified by whole-exome sequencing in a patient with Bosch-Boonstra-Schaaf optic atrophy syndrome. Indian J Ophthalmol, 2022, 70(7): 2762-2764.
|
21. |
Gazdagh G, Mawby R, Self JE, et al. Deciphering developmental disorders study: a severe case of bosch-boonstra-schaaf optic atrophy syndrome with a novel description of coloboma and septo-optic dysplasia, owing to a start codon variant in the NR2F1 gene. Am J Med Genet A, 2022, 188(3): 900-906.
|
22. |
Kingrey B, Phornphutkul C, Chen W. Bosch-Boonstra-Schaaf optic atrophy syndrome mimicking septo-optic dysplasia in a 10-year-old child. J AAPOS, 2021, 25(5): 314-316.
|
23. |
戈文蓉, 万林, 杨光. Boonsta-Bosch-Schaff视神经萎缩综合征并IESS1例报告并文献复习. 解放军医学杂志, 2020, 45(9): 940-946.
|
24. |
Starosta RT, Tarnowski J, Vairo FPE, et al. Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) initially diagnosed as ALG6-CDG: functional evidence for benignity of the ALG6 c. 391T>C (p. Tyr131His) variant and further expanding the BBSOAS phenotype. Eur J Med Genet, 2020, 63(7): 103941.
|
25. |
Billiet B, Amati-Bonneau P, Desquiret-Dumas V, et al. NR2F1 database: 112 variants and 84 patients support refining the clinical synopsis of Bosch-Boonstra-Schaaf optic atrophy syndrome. Hum Mutat, 2022, 43(2): 128-142.
|